Research.Patient.info
Refractory Metastatic Colorectal Cancer research hub
2 indexed studies · 2 currently recruiting
- recruitingNA
Amplitude Modulated Radiofrequency Electromagnetic Field Treatment Combined With TAS-102 (Lonsurf) and Bevacizumab in Refractory Metastatic Colorectal Cancer
This study is looking at a new way to treat advanced bowel cancer that has spread to the liver. It combines a special electrical field treatment with two existing cancer medicines (TAS-102 and Bevacizumab) for people who haven't responded to previous treatments.
Germany - recruitingPHASE2
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease
This study looks at a new way to treat bowel cancer that has spread to the liver. Half of the patients will get a special liver treatment plus standard drugs, and the other half will get standard drugs only. It aims to see if the liver treatment is safe and effective.
United States · Czechia · Germany